CD34 and Miyoshi myopathy: We previously reported CD34+ MM cells constitute only 2.20% of total MM cells in NDMM patients, but this fraction increased to 42.6% of MRD samples from MM patients, who achieved good responses (equal to or deeper than very good partial remission) [21].